XARCREDA Trademark

Trademark Overview

On Tuesday, February 19, 2013, a trademark application was filed for XARCREDA with the United States Patent and Trademark Office. The USPTO has given the XARCREDA trademark a serial number of 85853347. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 8, 2017. This trademark is owned by Novartis AG. The XARCREDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals
xarcreda

General Information

Serial Number85853347
Word MarkXARCREDA
Filing DateTuesday, February 19, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 8, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 8, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 8, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2016EXTENSION 5 GRANTED
Thursday, September 22, 2016EXTENSION 5 FILED
Thursday, September 22, 2016TEAS EXTENSION RECEIVED
Tuesday, April 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 2, 2016EXTENSION 4 GRANTED
Tuesday, March 29, 2016EXTENSION 4 FILED
Tuesday, March 29, 2016TEAS EXTENSION RECEIVED
Thursday, October 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2015EXTENSION 3 GRANTED
Sunday, September 27, 2015EXTENSION 3 FILED
Sunday, September 27, 2015TEAS EXTENSION RECEIVED
Thursday, May 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 6, 2015EXTENSION 2 GRANTED
Friday, March 27, 2015EXTENSION 2 FILED
Tuesday, May 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Wednesday, October 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 29, 2014EXTENSION 1 GRANTED
Monday, September 29, 2014EXTENSION 1 FILED
Monday, September 29, 2014TEAS EXTENSION RECEIVED
Tuesday, April 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 28, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, December 28, 2013ASSIGNED TO LIE
Wednesday, December 4, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 28, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 27, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 27, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 31, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, May 31, 2013PRIORITY ACTION E-MAILED
Friday, May 31, 2013PRIORITY ACTION WRITTEN
Tuesday, May 28, 2013ASSIGNED TO EXAMINER
Tuesday, February 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 22, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

xarcreda pharmaceutical preparations human system disorders treatment prevention namely diseases anti